Glioblastoma

• CLINICAL_TRIALS withdrawal · 2016-02-22
  Clinical Trial Update: Combining Radiotherapy and Temozolomide With Dichloroacetate in Patients With Newly Diagnosed Glioblastoma [Phase 1]

  Phase 1 trial of radiotherapy and temozolomide with dichloroacetate for newly diagnosed glioblastoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2016-02-15
  Clinical Trial Update: EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma [Phase 1, Phase 2]

  A Phase 1/Phase 2 trial evaluating EGFRBi-armed autologous T cells for adult brain glioblastoma and gliosarcoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-11-06
  Clinical Trial Update: Phase II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma [Phase 2]

  A Phase II trial evaluating sorafenib with radiation and temozolomide for newly diagnosed glioblastoma or gliosarcoma was withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-06-11
  Clinical Trial Update: New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma [Phase 1, Phase 2]

  This clinical trial update notes that the Newcastle Disease Virus (NDV) therapy trial for Glioblastoma, Sarcoma, and Neuroblastoma has been …

• CLINICAL_TRIALS withdrawal · 2015-05-22
  Clinical Trial Update: Valproic Acid in Childhood Progressive Brain Tumors [Phase 1]

  The trial withdrawal notice states that the Phase 1 study of valproic acid for childhood progressive brain tumors has been withdrawn.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS withdrawal · 2015-05-12
  Clinical Trial Update: Re-irradiation of High Grade Gliomas: a Quality of Life Study

  A clinical trial studying re-irradiation for high-grade gliomas with a quality-of-life focus has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-04-17
  Clinical Trial Update: Dose-Escalation Study of Carboplatin Administration Into the Brain for Glioblastoma Multiforme [Phase 1]

  A phase 1 dose-escalation trial evaluating carboplatin delivered into the brain for glioblastoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2015-03-11
  Clinical Trial Update: A Trial Of PF-04856884 In Patients With Recurrent Glioblastoma [Phase 2]

  This document notes a Phase 2 trial of PF-04856884 in recurrent glioblastoma that has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2014-06-02
  Clinical Trial Update: Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas [Phase 1]

  Phase 1 trial evaluating genetically modified stem cells with Irinotecan hydrochloride for recurrent high-grade gliomas has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2014-05-19
  Clinical Trial Update: Effects of Steroid Tapering on Functional Capacity and Neurocognition [NA]

  Duke University-sponsored trial evaluating steroid tapering effects on functional capacity and neurocognition in glioblastoma patients has b…

• CLINICAL_TRIALS withdrawal · 2014-01-14
  Clinical Trial Update: Peptide Vaccine for Glioblastoma Against Cytomegalovirus Antigens [Phase 1]

  A Phase 1 trial of a cytomegalovirus antigen–targeted peptide vaccine for glioblastoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-07-11
  Clinical Trial Update: Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 1, Phase 2]

  A Phase 1/2 trial investigating temozolomide plus carboplatin for recurrent glioblastoma multiforme has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2013-06-19
  Clinical Trial Update: A Panobinostat Presurgery [Phase 2]

  A presurgical Phase 2 trial of panobinostat for recurrent glioblastoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2012-11-21
  Clinical Trial Update: Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma [Phase 1]

  A Phase I trial of dasatinib in combination with protracted temozolomide for recurrent malignant glioma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2012-02-22
  Clinical Trial Update: Procarbazine and Isotretinoin in Treating Patients With Recurrent Primary Malignant Gliomas [Phase 3]

  A Phase 3 trial assessing procarbazine with isotretinoin for recurrent primary malignant gliomas has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2012-02-20
  Clinical Trial Update: SCH-900105 in Recurrent Glioblastoma [Phase 1]

  A Phase 1 trial of SCH-900105 for recurrent glioblastoma has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2011-12-20
  Clinical Trial Update: A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. [Phase 1]

  A Phase 1 clinical trial evaluating crizotinib in combination with a VEGF inhibitor for advanced solid tumors has been withdrawn.

• CLINICAL_TRIALS withdrawal · 2011-02-10
  Clinical Trial Update: Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy [Phase 3]

  A Phase 3 trial evaluating an anti-tenascin radiolabeled antibody therapy for glioblastoma has been terminated.

• CLINICAL_TRIALS withdrawal · 2009-05-20
  Clinical Trial Update: Safety Study of the Combination of Tandutinib With Temozolomide and Bevacizumab After Radiation and Temozolomide in Patients With Newly Diagnosed With Glioblastoma Multiforme [Phase 1]

  Phase 1 safety study of tandutinib in combination with temozolomide and bevacizumab for newly diagnosed glioblastoma; the trial has been wit…